Skip to main content

Sumitomo Pharma

Sumitomo Pharma Co Ltd is a Japanese pharmaceutical company developing prescription medicines in psychiatry, neurology, and oncology. The company researches, manufactures, and markets pharmaceutical products for central nervous system disorders, cancer, regenerative medicine, and rare diseases. Main revenue drivers stem from global sales of ethical pharmaceutical products, including treatments for schizophrenia, prostate cancer, and Parkinson's disease. Sumitomo Pharma serves hospitals, medical practitioners, prescription pharmacies, and patients in Japan, North America, China, and Europe. The company maintains an established market position as a research-driven pharmaceutical enterprise in Japan. Headquartered in Osaka, Japan, Sumitomo Pharma Co Ltd is listed on the Tokyo Stock Exchange.

8 of the funds FundTelligence covers report a position in Sumitomo Pharma.

Legal name
Sumitomo Pharma Co Ltd
Sector
Health Care
Country
Japan
Funds holding it
8

Funds holding Sumitomo Pharma

Loading...